Poll: What pipeline presbyopia treatment are you most looking forward to?

Poll

This poll is for optometrists and eyecare professionals, only. It will close on Friday, November 5, 2021.

What pipeline presbyopia treatment are you most looking forward to?

A. Orasis CSF-1
B. Allergan AGN-190584 drop
C. Eyenovia MicroLine drop
D. Presbyopia Therapies PRX-100
E. Ocuphire Pharma Nyxol
F. Visus Therapeutics Brimochol

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Related Content
Laboratory desk Image credit: AdobeStock/Shutter2U

Monthly pipeline update: A July news roundup

Jordana Joy, Associate Editor
August 23rd 2025
Article
Podcast: Visus presbyopia drop gets FDA IND OK

Podcast: Visus presbyopia drop gets FDA IND OK

Rhett Schiffman, MD, MHSA;Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director;Brooke Henson, Editor
August 23rd 2025
Podcast
Graphic displaying light entering the lens Image credit: EssilorLuxottica

Essilor announces release of new progressive lens to improve vision comfort for presbyopes

Jordana Joy, Associate Editor
August 23rd 2025
Article
Podcast: Find out more about Allergan’s presbyopia drop NDA filing

Podcast: Find out more about Allergan’s presbyopia drop NDA filing

Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director;Michael Robinson, MD;Brooke Henson, Editor
August 23rd 2025
Podcast
FDA accepts NDA for Tenpoint Therapeutics' brimochol PF for presbyopia ©Tada Images—stock.adobe.com

FDA accepts NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia

Emily Kaiser Maharjan, Assistant Managing Editor
August 23rd 2025
Article
New research reveals new marker for presbyopic accommodation - Image credit: ©TAGSTOCK2—stock.adobe.com

ARVO 2025: New research reveals new marker for presbyopic accommodation

Emily Kaiser Maharjan, Assistant Managing Editor
August 23rd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.